China’s growing prominence in cancer care stems from several key factors:
Massive investment in biotechnology infrastructure
Active participation in international clinical trials
Rapid development of CAR T-cell therapy and other cell-based treatments
Integrated approach combining Western medicine and Traditional Chinese Medicine (TCM)
Global partnerships and talent recruitment
With more than 5 million new cancer cases annually, China has developed a robust healthcare ecosystem to tackle this burden. Hospitals across the nation are equipped with the latest technologies like proton therapy, robotic surgeries, AI-based diagnostics, and next-generation sequencing.
CAR T-cell therapy, a form of personalized immunotherapy, has become a major focus for Chinese researchers and clinicians. China is one of the largest contributors to global CAR T clinical trials, especially for:
Hematological malignancies: B-cell leukemia, lymphoma, and multiple myeloma
Solid tumors: Lung, liver, pancreatic, and ovarian cancers
Chinese hospitals are now integrating dual-target CAR T therapies, armored CAR T cells, and allogeneic “off-the-shelf” approaches. This trend has led to higher remission rates, even in refractory cases.
Here’s a comprehensive list of the best hospitals for cancer treatment in China, each playing a pivotal role in patient care and research.
One of China’s oldest and most prestigious cancer hospitals, Fudan’s center is a leader in breast, lung, colorectal, and liver cancer care. It also has robust clinical trials in immunotherapy and chemotherapy. The hospital is a hub for precision medicine and translational oncology.
Renowned for its multidisciplinary care, Shanghai Cancer Hospital offers advanced treatment protocols and has one of the largest patient volumes in Asia. It is a leader in integrating radiotherapy and systemic treatments.
Beijing Gobroad is known for CAR T-cell therapy and gene editing research. With a focus on hematological cancers, the hospital is also a training center for emerging biotech professionals and a site for international clinical trials.
This institution stands out for its specialization in thoracic and gastrointestinal cancers. It also has a sophisticated imaging center for early cancer detection and precision diagnostics.
Dedicated to pediatric cancers, this hospital offers cutting-edge care for leukemia, lymphoma, and neuroblastoma. It is part of several global pediatric oncology collaborations.
Nanfang-Chinfu Children’s Institute of Hematology and Oncology
Boren Hospital excels in integrative oncology, combining Traditional Chinese Medicine (TCM) with modern protocols. It offers personalized treatment strategies for late-stage cancers and pain management.
A state-of-the-art facility in Shanghai, Jiahui caters to international patients. It provides comprehensive cancer care, including molecular diagnostics, chemotherapy, radiation, and supportive care.
This university hospital is a leader in translational cancer research and next-generation sequencing (NGS)-guided treatments. It has extensive clinical trials in targeted therapies and immuno-oncology.
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Puhua specializes in neuro-oncology and brain tumors. Its innovative protocols include stem cell therapy, CyberKnife radiosurgery, and minimally invasive interventions.
Originally known for neurosurgery, Tiantan has expanded into oncology with specialized centers for brain tumors and spine cancers. Its neuro-oncology division is among the best in Asia.
Focusing on childhood cancers, this hospital provides multidisciplinary pediatric oncology care with access to CAR T-cell therapy for leukemia and lymphoma in young patients.
This institute is a national reference center for hematologic cancers. It plays a major role in CAR T-cell development, stem cell transplants, and gene editing research.
Institute of Hematology and Blood Diseases, Chinese Academy of Medical Sciences, Tianjin
With world-class departments in breast, colorectal, and gastric cancers, this hospital conducts hundreds of clinical trials yearly. Its precision medicine platform supports genomic profiling for every cancer patient.
Peking University Cancer Hospital
An academic and clinical powerhouse, this hospital combines cancer research with elite clinical services, especially in lung, breast, and liver cancers.
The hospital’s cancer center is known for its collaborations with international biotech firms. It is also a trial site for new targeted therapies in EGFR-mutated and ALK-positive lung cancers.
This hospital bridges Hong Kong’s medical system and mainland China. It offers advanced imaging, robotic surgery, and international clinical trial access for patients in southern China.
Hong Kong University Shenzen Hospital
One of the most respected cancer hospitals in Asia, SYSUCC is involved in large-scale CAR T trials, checkpoint inhibitor studies, and drug discovery. Its pancreatic and nasopharyngeal cancer programs are world-renowned.
Sun Yat-Sen University Cancer Hospital
This unique institution promotes holistic oncology care. It uses acupuncture, herbal medicine, and dietary therapy alongside modern chemotherapy and immunotherapy.
Southen medical university of integrated Traditional Chinese and Western Medicine
Serving central China, this hospital is known for colorectal and liver cancer programs. It is also a key site for CAR T-cell therapy trials in multiple myeloma and B-cell lymphomas.
In addition to its neuro-oncology reputation, Tiantan Hospital is expanding its footprint in glioblastoma and CNS lymphoma treatment trials using targeted therapies.
Compared to Western nations, the cost of cancer treatment in China is significantly lower—often 50–70% less for similar treatments. This includes:
Chemotherapy and radiotherapy
Surgical procedures
Targeted therapies and immunotherapies
CAR T-cell therapy
While costs vary based on hospital and treatment complexity, the affordability and quality of care in China make it an attractive destination for international patients.
Access to the latest cancer innovations
Affordable costs compared to US or Europe
Global standard of care
Multilingual medical staff in top international hospitals
World-leading clinical trial programs
Whether you’re looking for early-stage diagnostics or advanced cancer care, China’s hospitals offer comprehensive, state-of-the-art solutions.
Navigating cancer treatment abroad can be overwhelming. That’s where CancerFax comes in.
We help patients connect with top cancer hospitals in China and provide end-to-end support, including:
Treatment planning and hospital selection
Cost estimates and travel logistics
Access to clinical trials and CAR T-cell therapy
Local language support and follow-up care
Visit www.cancerfax.com or email us at info@cancerfax.com to get started.
China is no longer just an emerging player in cancer treatment—it is a global leader. With some of the best hospitals for cancer treatment, cutting-edge therapies, and a thriving biotech ecosystem, it offers hope for patients worldwide. Whether you are seeking innovative immunotherapy or looking to enroll in a clinical trial, China is where science meets compassion.
Explore your options. Choose wisely. Choose healing.
Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.
Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.
Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.
Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.
These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.
Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.
Cancer hospitals in China, China, China Cancer Treatment, China Hospital, Shanghai, Shenzhen, Tianjin
CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.
Send your medical reports and get a free analysis.
🌟 Join us in the fight against cancer! 🌟
Привет,
CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.
Отправьте свои медицинские заключения и получите бесплатный анализ.
🌟 Присоединяйтесь к нам в борьбе с раком! 🌟